Loading stock data…
Loading stock data…
US$237.53
Get one email when AXSM crosses your level. Checked every 15 minutes during market hours.
▲ +2.27 (0.96%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
48.7
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.41
Bearish momentumMACD below its signal line (2.45).
200-day average
178.40
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and marketing therapies for central nervous system conditions with limited treatment options. Headquartered in New York City and founded in 2012, the company concentrates on neuropsychiatric and neurological disorders such as major depressive disorder, excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea, Alzheimer’s disease agitation, migraine, narcolepsy, and fibromyalg…
www.axsome.com10 strong buy · 15 buy · 2 hold · 0 sell · 0 strong sell (27 analysts, 2026-07-01)
10 strong buy · 15 buy · 2 hold · 0 sell · 0 strong sell (27 analysts, 2026-06-01)
10 strong buy · 15 buy · 2 hold · 0 sell · 0 strong sell (27 analysts, 2026-05-01)
9 strong buy · 15 buy · 2 hold · 0 sell · 0 strong sell (26 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-22 | 1.34 | 1.78 | ✓ Beat |
| 2026-05-04 | -0.86 | -1.26 | ✗ Miss |
| 2026-03-04 | 0.06 | 0.15 | ✓ Beat |
| 2026-02-23 | -0.73 | -0.56 | ✓ Beat |
| 2026-01-23 | 1.61 | 1.87 | ✓ Beat |
| 2025-11-03 | -0.9 | -0.94 | ✗ Miss |
| 2025-08-04 | -1.09 | -0.97 | ✓ Beat |
Companies in the same industry, via Finnhub